MDxHealth SA
MDXH
$1.48
-$0.02-1.33%
| 06/30/2023 | 03/31/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 13.91% | 14.03% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.91% | 14.03% | |||
| Cost of Revenue | 12.87% | 5.61% | |||
| Gross Profit | 14.63% | 20.64% | |||
| SG&A Expenses | 7.49% | -2.05% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -218.51% | 205.49% | |||
| Total Operating Expenses | 1.16% | 5.33% | |||
| Operating Income | 20.35% | 6.67% | |||
| Income Before Tax | 9.25% | 4.88% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 9.25% | 5.86% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 9.25% | 5.86% | |||
| EBIT | 20.35% | 6.67% | |||
| EBITDA | 27.03% | 8.98% | |||
| EPS Basic | 38.15% | 31.59% | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | 38.15% | 31.59% | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | 46.74% | 37.61% | |||
| Average Diluted Shares Outstanding | 46.74% | 37.61% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
